Scientists at Saint Louis University and the University of Alabama at Birmingham have uncovered important new information about a key protein that allows viruses such as smallpox to replicate and ...

The drug tecovirimat is currently in use for the treatment of mpox -- the disease caused by monkeypox virus -- that spread worldwide in 2022. Tecovirimat is an anti-poxviral drug, and its use is ...

New research reveals that high concentrations of resveratrol — a compound that is found in red wine and chocolate — can stop poxviruses from multiplying in human cells. Share on Pinterest A compound ...

We must prepare for the possibility that a zoonotic poxvirus could become a highly infectious human pathogen. Our already-fragile health systems cannot afford to be caught in another global pandemic ...

Poxviruses, which are responsible for smallpox and other diseases, can adapt to defeat different host antiviral defenses by quickly and temporarily producing multiple copies of a gene that helps the ...

Smallpox has been eradicated for decades, but other, related "poxviruses" are still around and continue to pose a risk to humans, experts say. In fact, cases of human infection with viruses in the ...

The tyrosine kinase inhibitor Gleevec, currently used to treat cancers such as chronic myeloid leukemia, can also function as an antiviral drug to treat poxvirus infections (pages 731–739). The ...

Poxviruses have found a unique way of translating their genes into proteins in the infected organism. A team of researchers from Würzburg shows for the first time how the molecular machinery involved ...

Nitazoxanide (NTZ), a compound approved by the Food and Drug Administration for the treatment of diarrhea in patients infected by the Cryptosporidium and Giardia intestinalis species, is used ...

Scientists studying how poxviruses evade natural defences in human cells have identified a new approach to treatment that may be more durable than current treatments. This follows their discovery of ...